[{"Assets_0_Q3_USD":606110000.0,"CommonStockSharesOutstanding_0_Q3_shares":43945316.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-107427000.0,"NetIncomeLoss_1_Q3_USD":-72723000.0,"NetIncomeLoss_3_Q3_USD":-156320000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":43915376.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":43824773.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":43915376.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":43824773.0,"StockholdersEquity_0_Q3_USD":489296000.0,"Ticker":"BPMC","CIK":"1597264","name":"BLUEPRINT MEDICINES CORP","OfficialName":"Blueprint Medicines Corporation Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"3980842399.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181030"}]